Regulation of central corticosteroid receptors following short-term activation of serotonin transmission by 5-hydroxy-L-tryptophan or fluoxetine

Journal of Neuroendocrinology

Volumn 12, Issue 8, 2000, Pages 736-744

  Semont A ^a   Fache, M P ^a   Hery F ^a   Faudon, M ^a   Youssouf, F ^a   Hery M ^a  

^a INSERM   (France)

Author keywords

5 HTP; Corticosteroid receptors; Fluoxetine; Hippocampus; Hypothalamus; Rat; Serotonin

Indexed keywords

5 HYDROXYTRYPTOPHAN; ANTIDEPRESSANT AGENT; AUTORECEPTOR; CORTICOSTEROID RECEPTOR; CORTICOSTERONE; FLUOXETINE; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPUS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; RECEPTOR UPREGULATION;

5-HYDROXYTRYPTOPHAN; ADMINISTRATION, ORAL; ADRENALECTOMY; ANIMALS; BINDING SITES; BRAIN STEM; CENTRAL NERVOUS SYSTEM; CORTICOSTERONE; FLUOXETINE; HIPPOCAMPUS; HYDROXYINDOLEACETIC ACID; HYPOTHALAMUS; MALE; OCCIPITAL LOBE; RATS; RECEPTORS, MINERALOCORTICOID; RECEPTORS, STEROID; RNA, MESSENGER; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SYNAPTIC TRANSMISSION;

EID: 0033930750     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.2000.00509.x     Document Type: Article

References (44)

1. Physiopharmacological interactions between stress hormones and central serotoninergic systems
2. Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats
3. Regulation of 5-HT receptors by corticosteroids: Where do we stand?
4. Corticosterone and serotonergic neurotransmission in the hippocampus: Functional implications of central corticosteroid receptor diversity
5. Distribution of the mineralocorticoid and the glucocorticoid receptor mRNAs in the rat hippocampus
6. Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation
7. Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vivo autoradiography and computerized image analysis
8. Diurnal differences in basal and acute stress levels of type I and type II adrenal steroid receptor activation in neural and immune tissues
9. Antidepressants and hypothalamic-pituitary-adrenocortical regulation
10. Role of serotonin in depression
11. Antidepressants increase glucocorticoid and mineral-ocorticoid receptor mRNA expression in rat hippocampus in vivo
12. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system
13. The SSRIs: Advantages, disadvantages and differences
14. Short-term and long-term effects of p-chloroamphetamine on hippocampal serotonin and corticosteroid receptor levels
15. Site-specific regulation of corticosteroid and serotonin receptor subtype gene expression in the rat hippocampus following 3,4-methylenedioxymethamphetamine: Role of corticosterone and serotonin
16. Effect of serotonin inhibition on glucocorticoid and mineralocorticoid expression in various brain structures
17. Adrenal steroid type I and type II receptor binding: Estimates of in vivo receptor number, occupancy, and activation with varying level of steroid
18. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
19. Effect of passive immunization against corticotropin-releasing factor (CRF) on the post-adrenalectomy changes of CRF binding sites in the rat anterior pituitary gland
20. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
21. Corticosteroid receptor mRNA expression is unaffected by corticosteroids in rat kidney, heart, and colon
22. Genetic complementation of glucocorticoid receptor deficiency by expression of cloned receptor cDNA
23. Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein
24. Regulation of glucocorticoid receptor expression: Evidence for transcriptional and posttranslational mechanisms
25. Concurrent determination of effects of, p-chloroamphetamine on central extracellular 5-hydroxytryptamine concentration and behavior
26. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum
27. Acute uptake inhibition increases extracellular serotonin in the rat forebrain
28. Short-term fluoxetine treatment alters monoamine levels and turnover in discrete brain nuclei
29. Regional differences in the response of serotoninergic neurons in rat CNS to drugs
30. Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: Evidence for the involvement of both 5-HT1A and 5-HT 1B/D autoreceptors
31. Influence of fluoxetine on regional serotonin synthesis in the rat brain
32. Glucocorticoid and mineralocorticoid receptor mRNA expression in rat brain
33. Type I and type II corticosteroid receptor gene expression in the rat: Effect of adrenalectomy and dexamethasone administration
34. Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat
35. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100635 and GR 127935
36. Opposite effects on hippocampal corticosteroid receptors induced by stimulation of beta and alpha 1 noradrenergic receptors
37. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis study
38. Effects of acute fluoxetine on extracellular serotonin levels in the raphe: An in vivo microdialysis study
39. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1a receptor antagonist
40. Fluoxetine-induced desensitization of somatodendritic 5-HT1A autoreceptors is independent of glucocorticoid(s)
41. Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation
42. Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex
43. The effects of serotonin on glucocorticoid receptor binding in rat raphe nuclei and hippocampal cells in culture
44. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine